Domov › Kolorektalni rak › Minnesota › Minneapolis
Klinične študije za Kolorektalni rak v Minneapolis, MN
19 študij za Kolorektalni rak išče udeležence na lokacijah v Minneapolis in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Minneapolis VA Medical Center, Minneapolis
Family Communications After Genetic Testing
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
PRE-ISPY Phase I/II Oncology Platform Program
Vključevanje udeležencevFaza 1/2
- University of Minnesota Masonic Cancer Center, Minneapolis
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Vključevanje udeležencevFaza 3
- University of Minnesota/Masonic Cancer Center, Minneapolis
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Vključevanje udeležencevFaza 1/2
- Masonic Cancer Center University of Minnesota, Minneapolis
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Vključevanje udeležencevFaza 3
- Minnesota Oncology Hematology, P.A., Saint Louis Park · 5 mi stran
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Vključevanje udeležencevFaza 3
- Clinical Study Site, Saint Louis Park · 5 mi stran
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- University of Minnesota Masonic Cancer Center, Minneapolis
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Vključevanje udeležencevFaza 1/2
- University of Minnesota/Masonic Cancer Center, Minneapolis
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Vključevanje udeležencevFaza 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Vključevanje udeležencevFaza 3
- Allina Health Cancer Institute (Virginia Piper Cancer Institute), Minneapolis
- Minnesota Oncology Hematology, PA, Minneapolis
- Hennepin County Medical Center, Minneapolis
- in še 3
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Vključevanje udeležencevFaza 2
- Scri Minnesota Oncology Hematology, P.A. /ID# 275149, Minneapolis
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Vključevanje udeležencevOpazovalna študija
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Allina Health Cancer Institute, Minneapolis
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Vključevanje udeležencevOpazovalna študija
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Vključevanje udeležencevOpazovalna študija
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 mi stran
Študije za Kolorektalni rak v drugih mestih
- Houston, TX102 študij
- New York City, NY78 študij
- Nashville, TN69 študij
- Boston, MA63 študij
- Los Angeles, CA59 študij
- Arlington, VA52 študij
- St. Louis, MO50 študij
- San Antonio, TX46 študij
- Philadelphia, PA44 študij
- Grand Rapids, MI40 študij
- Baldwin Park, CA37 študij
- Chicago, IL34 študij
Druge študije v Minneapolis
- Nemalicelični pljučni rak27 študij
- Rak dojke27 študij
- Rak jajčnikov24 študij
- Rak prostate23 študij
- Rak (vse vrste)22 študij
- Srčno popuščanje21 študij
- Akutna mieločna levkemija20 študij
- Rak pljuč20 študij
- Rak endometrija18 študij
- Parkinsonova bolezen17 študij
- Srčno-žilne bolezni15 študij
- Bolezen venčnih arterij13 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.